SOURCE: Skystar Bio-Pharmaceutical Company

January 17, 2007 09:30 ET

Skystar Bio-Pharmaceutical to Present at the Small Cap/Growth Informed Investors Forum

XI'AN, CHINA -- (MARKET WIRE) -- January 17, 2007 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it will be one of the featured presenters at the upcoming Small Cap/Growth Informed Investors Forum on January 24, 2007. The forum targets high net-worth, self-directed personal and professional portfolio managers who are carefully researching investment options in the Small Cap/Growth stock arena. Scott Cramer, Skystar Bio-Pharmaceutical's Director of Investor Relations, will present the Company's investment story and future growth potential to all participating investors.

WHAT:   Skystar Bio-Pharmaceutical Presentation at Small Cap/Growth
        Informed Investors Online Forum

WHEN:   Wednesday, January 24, 2007 - 10:00 a.m. Eastern Time

HOW:    Live over the internet by logging on to:
        http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=111816

REPLAY: An archive of the presentation will be available immediately
        after its conclusion at
        http://www.informedinvestors.com/IIF/IIF_Client.asp?clientID=46725.

RSVP:   To register for the presentation or to be added to Skystar
        Bio-Pharmaceutical's e-mail distribution list, please contact
        Zack Noory, Managing Partner of Nexus Investor Relations at
        310-606-2018 or via email at znoory@nexusir.com.

About Informed Investors Forum

One of the most efficient and effective methods for delivering a corporate message to high net-worth investors is through an Investor Forum. Companies present their story directly to experienced and engaged investors in a format that bypasses the tangle of traditional media outlets. Last year over 18,000 investors utilized Informed Investors Forums to help find their next stake. These are high net-worth, self-directed personal and professional portfolio managers who are carefully researching and weighing their investment options. Founded in 1993, Informed Investors offers a conduit for companies to present their IR message through industry-specific forums directly to investors without media or analyst filters. We give companies the opportunity to provide the transparency investors are seeking. Our forums are conducted both over the Internet and in person through onsite investor conferences.

About Skystar Bio-Pharmaceutical

Skystar Bio-Pharmaceutical Company is a China-based producer and distributor of vaccines, microorganisms and 100% organic herbal additives to cure and prevent disease in poultry, livestock, birds and pets. The company's product line consists of more than 70 state-of-the-art products with over 50 additional products in the developmental stage. One of the prominent products currently in the development stage is a feed additive and vaccine for Avian Influenza. Skystar has formed strategic sales distribution networks in 27 provinces and regions throughout China. Skystar recently completed construction of new state-of-the-art Bio-Pharmaceutical facilities covering an area of almost eight acres. The new facilities meet or exceed all Good Manufacturing Practice (GMP) Certification Standards and have received GMP Certification from the Chinese government. For additional information, please visit www.skystarbio-pharmaceutical.com.

Forward-looking statement: Except for the historical information, the matters discussed in this news release may contain forward-looking statements, including, but not limited to, factors relating to future sales. These forward-looking statements may involve a number of risks and uncertainties. Actual results may vary significantly based on a number of factors, including, but not limited to, uncertainties in product demand, the impact of competitive products and pricing, changing economic conditions around the world, release and sales of new products and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission.

Contact Information

  • AT SKYSTAR BIO-PHARMACEUTICAL:
    Scott Cramer
    Director - Investor Relations
    407-645-4433
    Email Contact

    AT NEXUS INVESTOR RELATIONS:
    Zack Noory
    Managing Partner
    310-606-2018
    Email Contact